Impact of depression severity on quality of life and functional impairment: a comparative cross-sectional study
DOI:
https://doi.org/10.18203/2394-6040.ijcmph20263185Keywords:
MDD, QoL, Functional ImpairmentAbstract
Background: Major depressive disorder (MDD) is a widespread health issue linked to high mortality rates, functional impairment, disability, increased healthcare expenses, reduced quality of life, and psychosocial dysfunction. Dysfunction in social participation, productivity, and sense of subjective well-being persists even after reduction in depressive symptoms. Achieving symptomatic remission is not enough in the treatment of depression, but also understanding, assessing functional impairment, and Quality of Life together with symptom severity should be a holistic approach for the treatment of depression.
Methods: A cross-sectional comparative study design was used. 60 individuals with depression samples were collected based on the purposive sampling method from a tertiary care hospital. Another 60 samples were collected from the general population for the normal control group on the basis of inclusion and exclusion criteria.
Results: There were significant differences found in all four domains of QoL between the experimental and control groups, where the normal control group outperformed in all four domains of QoL with higher mean scores than the experimental group. The global score of the experimental group in WHODAS varies significantly (p=0.00) from the control group. The experimental group has higher dysfunction (83.28±10.29) in comparison to the control group (59.50±9.54).
Conclusions: Functional impairment and QoL functioning are significantly affected in persons with depression. Shifting focus from only depression symptoms severity to consideration of functional impairment and QoL functioning would be a holistic approach for depression assessment and management.
References
Gilmour H, Patten SB. Depression and work impairment. Health Rep. 2007;18(1):9-22.
Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS. Grand challenges in global mental health. Nature. 2011;475(7354):27-30.
Bentley KH, Gallagher MW, Carl JR, Barlow DH. Development and validation of the overall depression severity and impairment scale. Psychol Assess. 2014;26(3):815-30.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas AR, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-105.
Kennedy N, Foy K, Sherazi R, McDonough M, McKeon P. Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disord. 2007;9(1-2):25-37.
McKnight PE, Kashdan TB. The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clin Psychol Rev. 2009;29(3):243-59.
Hardeveld F, Spijker J, De Graaf R, Nolen WA, Beekman ATF. Prevalence and predictors of recurrence of major depressive disorder in the adult population. Acta Psychiatr Scand. 2010;122(3):184-91.
Judd LL, Akiskal HS, Zeller PJ, Paulus M, Leon AC, Maser JD, et al. Psychosocial disability during the long-term course of unipolar major depressive disorder. Arch Gen Psych. 2000;57(4):375-80.
Lam RW, Kennedy SH, McIntyre RS, Khullar A. Cognitive dysfunction in major depressive disorder: effects on psychosocial functioning and implications for treatment. Can J Psychiatry. 2014;59(12):649-54.
Gureje O, Kola L, Afolabi E. Epidemiology of major depressive disorder in elderly Nigerians in the Ibadan Study of Ageing: a community-based survey. Lancet. 2007;370(9591):957-64.
Ayuso-Mateos JL, Nuevo R, Verdes E, Naidoo N, Chatterji S. From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry. 2010;196(5):365-71.
Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370(9590):851-58.
Fried EI, Nesse RM. The impact of individual depressive symptoms on impairment of psychosocial functioning. PLoS One. 2014;9(2):e90311.
Park EH, Jung MH. The impact of major depressive disorder on adaptive function: a retrospective observational study. Medicine (Baltimore). 2019;98(52):e18515.
Hoa TTM, Ngan TT, Mai VQ, Minh HV, Thu NK, Nhu TK. Health-related quality of life of people with depression: pre-post intervention compared with age-matched general population in Vietnam. BMC Psychol. 2024;12(1):565.
Saarijärvi S, Salminen JK, Toikka T, Raitasalo R. Health-related quality of life among patients with major depression. Nord J Psych. 2002;56(4):261-4.
Hammer-Helmich L, Haro JM, Jönsson B, Tanguy Melac A, Di Nicola S, Chollet J, et al. Functional impairment in patients with major depressive disorder: the 2-year PERFORM study. Neuropsychiatr Dis Treat. 2018;14:239-49.
Zhou J, Feng L, Feng Y, Xiao L, Chen X, Yang J, et al. The associations between depressive symptoms, functional impairment, and quality of life in patients with major depression: undirected and Bayesian network analyses. Psychol Med. 2023;53(14):6446-58.
Downloads
Published
How to Cite
Issue
Section
